The PANTS (Personalised Anti-TNF Therapy in Crohn’s Disease) study, the largest prospective study of 955 luminal CD patients (≥6 years) treated with IFX, found that low IFX concentrations at week 14 were associated with non-response and ATI occurrence [15]. Here, TNF is linked to Crohn disease.